PublishedSeptember 23, 2021 Category Publications Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial.
PublishedSeptember 15, 2021 Category Publications The Role of Suboptimal Concentrations of Nebulized Tobramycin in Driving Antimicrobial Resistance in Pseudomonas aeruginosa Isolates in Cystic Fibrosis.
PublishedJuly 13, 2021 Category Partner News Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial
PublishedJune 25, 2021 Category PARI News Dr. Stefan Seemann is appointed President of PARI Pharma GmbH
PublishedJune 7, 2021 Category PARI Publications How Cold Is Cold Enough? Refrigeration of the Next-Generation Impactor to Prevent Aerosol Undersizing.
